
Release date: 2026-01-28 17:12:41 Article From: Lucius Laos Recommended: 11
Revuforj is typically indicated for the treatment of patients with specific types of acute leukemia.
Revuforj manufactured by Lucius Pharmaceuticals is available in three standard specifications, namely: a pack containing 30 tablets with a dosage of 25mg per tablet; a pack containing 30 tablets with a dosage of 110mg per tablet; and a pack containing 30 tablets with a dosage of 160mg per tablet.
Regarding the drug price, it may vary due to factors such as different regions, sales channels, market supply and demand, and exchange rate fluctuations. It is recommended to refer to the actual selling price announced by local pharmacies or official channels when purchasing.
Patients with certain types of acute leukemia have a genetic alteration known as KMT2A (Lysine Methyltransferase 2A) translocation. These patients produce the KMT2A protein, which binds to another protein called menin. This protein-protein interaction drives the proliferation of acute leukemia cells. Revuforj is classified as a menin inhibitor. The drug blocks this protein-protein interaction, thereby promoting the development of normal blood cells.
To ensure the stability of efficacy and safe use of Revuforj, please follow the below storage conditions and recommendations:
Revuforj should be stored at room temperature, with an ideal range of 20°C to 25°C (68°F to 77°F).
For necessary short periods (e.g., transportation from the pharmacy to home), Revuforj may be exposed to a temperature range of 15°C to 30°C (59°F to 86°F). This is only for brief durations and should not be used as a long-term storage condition.
Environment: Store the drug in a cool, dry place, away from light, moisture and excessive heat.
Packaging: Always keep the drug in its original container. The original container is specially designed with light-proof and moisture-proof features to provide optimal protection. Do not transfer the drug to other containers arbitrarily.
Do not freeze this product in a refrigerator unless specifically instructed by the drug label or a pharmacist.
Avoid storing the drug in humid areas such as the bathroom or near the kitchen sink, or in overheated locations such as near car windows or heating appliances.
Keep the drug out of the reach of children and pets.
Adherence to the above storage guidelines helps maintain the quality and efficacy of Revuforj. If you have any uncertainties, consult your physician or pharmacist.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:732025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3692024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:652025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:822025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:822025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:982025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:942025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:952025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: